Skip to content

Heart and Renal Failure in Hip Fracture Surgery

Heart and Renal Failure in Hip Fracture Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03532919
Enrollment
105
Registered
2018-05-22
Start date
2018-02-01
Completion date
2018-12-01
Last updated
2018-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Injuries, Hip Fractures, Hypotension, Renal Insufficiency

Brief summary

Patients with acute hip fractures are old and vulnerable. With a majoriry classified as being ASA 3 or more. Frequently they receive spinal anesthesia perioperatively inducing hypotension. Even a short hypotensive period may induce postop cardiac T roponinT leakage as well as renal failure noted by Changes in Serum Creatinin or Cýstatin C This will be investigated and correlated to intraoperative hypotension as step one. Preliminary this will be followed by an intervention with vasopressor treatment perioperatively to preserve an adequte MABP

Detailed description

Patients with acute hip fractures are old and vulnerable. With a majoriry classified as being ASA 3 or more. Frequently they receive spinal anesthesia perioperatively inducing hypotension. Even a short hypotensive period may induce postop cardiac T roponinT leakage as awell as renal failure noted by Changes in S Creatinin or Cýstatin C This will be investigated and correlated to intraoperative hypotension as a step one. Preliminary this will be followed by an intervention with vasopressor treatment perioperatively to preserve an adequte MABP

Interventions

DIAGNOSTIC_TESTSerum Tropinin

Blodsamples will be taken 4 times from preoperatively to 2 Days postoperatively

Sponsors

Sahlgrenska University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Hip fracture patient to be operated upon Classified as being ASA 3 or more

Exclusion criteria

* Not forfilling inclusion Criterias

Design outcomes

Primary

MeasureTime frameDescription
Mortality90 dayspost surgery

Secondary

MeasureTime frameDescription
Serum concentrations of Troponin, NTproBNP, Creatinin and Cystatin C90 daysRelations between values and mortality at 30 and 90 days

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026